Monacolin K in red yeast rice can lower low-density lipoprotein levels
06/03/2019 // Evangelyn Rodriguez // Views

This paper describes a randomized, double-blind, placebo-controlled intervention study conducted by researchers from the Leibniz University Hannover in Germany to evaluate the effects of a low moncacolin K dose and folic acid on plasma lipids and homocysteine levels, respectively. The results of their analyses were published in the journal Nutrition Research.

  • Hypercholesterolemia and elevated homocysteine concentrations are associated with cardiovascular risk.
  • Previous studies have shown that red yeast rice (RYR) supplements containing 5 to 10 milligrams (mg) of monacolin K can lower cholesterol levels.
  • The researchers hypothesized that a low monacolin K dose could reduce low-density lipoprotein–cholesterol (LDL-C) and other plasma lipids.
  • They also tested the ability of folic acid to lower homocysteine; folic acid was included in the study preparation.
  • They randomly assigned 142 nonstatin-treated participants with hypercholesterolemia (LDL-C ? 4.14 ? 5.69 mmol/L) to either the treatment group or the placebo group.
  • Participants of the treatment group consumed 3 mg monacolin K and 200 micrograms (ug) folic acid per day.
  • The researchers found a significant (P < .001) reduction in LDL-C (?14.8 percent), total cholesterol (?11.2 percent), and homocysteine (?12.5 percent) in the treatment group after 12 weeks.
  • They also noted that 51 percent of the participants treated with RYR achieved the limit of LDL-C (<4.14 mmol/L) advised, and 26 percent reached the threshold level of homocysteine (<10 umol/L).
  • Meanwhile, they observed no significant changes in the placebo group; they reported no intolerance or any serious adverse events.

Based on these results, the researchers concluded that taking a low dose of 3 mg monacolin K from RYR daily reduces the concentration of LDL-C, which is a risk factor for cardiovascular diseases.

Read the full text of the study at this link.

Journal Reference:

Heinz T, Schuchardt JP, Möller K, Hadji P, Hahn A. LOW DAILY DOSE OF 3 MG MONACOLIN K FROM RYR REDUCES THE CONCENTRATION OF LDL-C IN A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION. Nutrition Research. October 2016;36(10):1162–1170. DOI: 10.1016/j.nutres.2016.07.005

Take Action:
Support Natural News by linking to this article from your website.
Permalink to this article:
Embed article link:
Reprinting this article:
Non-commercial use is permitted with credit to (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
App Store
Android App
eTrust Pro Certified

This site is part of the Natural News Network © 2022 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
Natural News uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.